Literature DB >> 9809461

Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS.

V Lessmann1.   

Abstract

1. The protein family of the neurotrophins, consisting of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and Neurotrophin-3, -4/5, and -6 (NT-3; NT-4/5; NT-6) is well known to enhance the survival and to stabilize the phenotype of different populations of neurons in the central and the peripheral nervous system. These effects are mediated via binding to specific tyrosine kinase receptors (Trks) and to the low-affinity p75 neurotrophin receptor. 2. The neurotrophins NGF, BDNF, and NT-3 and the BDNF and NT-3 selective receptors (TrkB, TrkC) are expressed at high levels in neurons of the basal forebrain, the hippocampus, and the neocortex of the mammalian brain. The expression and secretion of NGF and BDNF in these brain areas is regulated by (physiological levels of) neuronal activity. 3. Exogenous application of the neurotrophins to hippocampal and neocortical neurons can enhance excitatory glutamatergic synaptic transmission via activation of Trk receptors. In addition, long-term potentiation (a potential cellular correlate for learning and memory formation in mammals) in the rodent hippocampus depends on endogenous supply of neurons with BDNF. 4. Judged by the analysis of electrophysiological data, the BDNF- and NT-3-induced enhancement of glutamatergic synapses is mediated by increasing the efficacy of glutamate release from the presynaptic neuron. However, neurotrophin-dependent postsynaptic enhancement of NMDA (but not AMPA) receptor responsiveness has also been shown. 5. On the molecular level, neither the pre- nor the postsynaptic modulation of glutamatergic synapses by neurotrophins is well understood. However, neurotrophins were shown to acutely affect intraneuronal Ca2+ levels and to influence molecular components of the transmitter release machinery, which could underly the presynaptic modifications, whereas BDNF-induced phosphorylation of NMDA-type glutamate receptors could account for the postsynaptic effects. 6. Taken together, these results suggest that the activity-dependent release of neurotrophins at frequently used synapses could modulate the synaptic efficacy at these junctions. Thus, neurotrophins might operate as locally released feedback modulators of synaptic transmission, and this could be a cellular correlate for certain aspects of information processing in the mammalian brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9809461     DOI: 10.1016/s0306-3623(98)00190-6

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  60 in total

1.  Transcriptional analysis in the brain: trophin-induced hippocampal synaptic plasticity.

Authors:  Janet Alder; Smita Thakker-Varia; Ira B Black
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

2.  BDNF and DYRK1A are variable and inversely correlated in lymphoblastoid cell lines from Down syndrome patients.

Authors:  Asma Tlili; Alexander Hoischen; Clémentine Ripoll; Eva Benabou; Anne Badel; Anne Ronan; Renaud Touraine; Yann Grattau; Samantha Stora; Bregje van Bon; Bert de Vries; Björn Menten; Nele Bockaert; Joseph Gecz; Stylianos E Antonarakis; Dominique Campion; Marie-Claude Potier; Henri Bléhaut; Jean-Maurice Delabar; Nathalie Janel
Journal:  Mol Neurobiol       Date:  2012-06-05       Impact factor: 5.590

3.  The functional consequences of changes in the strength and duration of synaptic inputs to oscillatory neurons.

Authors:  Astrid A Prinz; Vatsala Thirumalai; Eve Marder
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

Review 4.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

Review 5.  Neurotrophic effects of AMPA.

Authors:  Cristina Limatola
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

6.  Calcium-dependent activator protein for secretion 2 (CAPS2) promotes BDNF secretion and is critical for the development of GABAergic interneuron network.

Authors:  Yo Shinoda; Tetsushi Sadakata; Kazuhito Nakao; Ritsuko Katoh-Semba; Emi Kinameri; Asako Furuya; Yuchio Yanagawa; Hajime Hirase; Teiichi Furuichi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 7.  Electrophysiological insights into the enduring effects of early life stress on the brain.

Authors:  Idrish Ali; Michael R Salzberg; Chris French; Nigel C Jones
Journal:  Psychopharmacology (Berl)       Date:  2010-12-17       Impact factor: 4.530

Review 8.  Glutamate and neurotrophic factors in neuronal plasticity and disease.

Authors:  Mark P Mattson
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 10.  BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses.

Authors:  Kurt Gottmann; Thomas Mittmann; Volkmar Lessmann
Journal:  Exp Brain Res       Date:  2009-09-24       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.